Omega-3脂肪酸：全面指南，了解其益处、来源和补充方式

并非所有的Omega-3都是相同的。主要有三种类型，具有根本不同的生理作用：

**ALA（α-亚麻酸）：** 存在于植物性食物中——亚麻籽、奇亚籽、 hemp种子、核桃、菜籽油。ALA是一种“必需”脂肪酸——身体无法合成，必须通过饮食获取。然而，ALA的直接生理活性有限；它的价值主要在于转化为EPA和DHA，而这种转化效率极低（通常5-10%转化为EPA；不足1%转化为DHA）。

**EPA（二十碳五烯酸）：** 存在于油性鱼类、海鲜和藻类中。主要的抗炎Omega-3。EPA减少促炎性类花生酸的产生，支持心血管健康，并与情绪调节有关。

**DHA（二十二碳六烯酸）：** 存在于油性鱼类、海鲜、藻类和以藻类喂养的鸡蛋中。结构性Omega-3——是全身细胞膜的重要组成部分，尤其是在大脑中（60%的大脑脂肪是DHA）和视网膜。对胎儿大脑发育和一生的认知功能至关重要。

**实际意义：** 植物性Omega-3来源（ALA）有价值，但对于大多数人来说不足以作为唯一来源。EPA和DHA——来自油性鱼类或藻类——是维持最佳健康所必需的。

**心血管健康：** 研究最广泛的益处。EPA和DHA以2-4g/天的剂量减少甘油三酯15-30%——这是一个公认的、临床上有意义的效果。在REDUCE-IT试验（2018年）中，高剂量EPA（4g/天，作为Vascepa/icosapent ethyl）在甘油三酯升高的人群中显示出25%的主要心血管事件减少。

对总心血管死亡率的影响更为复杂：2018年的VITAL试验（25,871名参与者）显示Omega-3组心脏病发作减少28%；后续的荟萃分析显示在心脏病发作预防方面具有一致的心血管益处。

**脑健康：** DHA是大脑中的主要结构脂肪。观察性研究一致表明，较高的Omega-3摄入与认知衰退和阿尔茨海默病风险降低相关。对轻度认知障碍患者的干预试验显示出适度但一致的益处。

**炎症：** EPA与花生四烯酸（AA）竞争转化为类花生酸。较高的EPA使生产转向较少的炎症化合物，降低全身炎症标志物（CRP，IL-6）。证据支持其在类风湿性关节炎、炎症性肠病和银屑病中的使用。

**心理健康：** 关于Omega-3在抑郁症中的作用的证据日益增加。2019年在《转化精神病学》中的一项荟萃分析发现EPA补充显著减少抑郁症状。效果在临床抑郁症患者中最为明显，并且与抗抑郁药物具有叠加效果。

**每份EPA+DHA含量最高的油性鱼类：** • 鲭鱼（100g熟）：2,500mg EPA+DHA • 野生三文鱼（100g）：1,800-2,200mg • 青鱼（100g）：1,700mg • 油罐装沙丁鱼（100g）：1,400mg • 凤尾鱼（30g）：500mg • 罐装金枪鱼（100g）：150-300mg（较低——金枪鱼较瘦，油被排出）

**植物来源（仅ALA）：** • 亚麻籽粉（1汤匙）：1,600mg ALA • 奇亚籽（1汤匙）：1,900mg ALA • Hemp种子（3汤匙）：2,600mg ALA • 核桃（30g）：2,600mg ALA • 菜籽油（1汤匙）：1,300mg ALA

**建议：** 每周吃2-3次油性鱼类。英国国民健康服务和美国心脏协会均建议每周至少吃2份鱼，其中至少1份为油性鱼。

鱼油补充剂市场年收入超过300亿美元，但标准补充剂剂量的证据比市场营销所暗示的更为复杂。

**证据显示：** 大多数标准鱼油补充剂（1g/天，提供300-500mg EPA+DHA）的随机对照试验显示对心血管硬性结果的影响适度或不一致。明显的益处出现在更高剂量（2-4g/天 EPA+DHA）和甘油三酯升高或已有心血管疾病的人群中。

**补充剂质量至关重要：** 鱼油迅速氧化。变质的Omega-3补充剂可能有害而非有益。选择： • 具有NSF国际、USP或IFOS认证的产品 • 标签上显示总氧化值（TOTOX）低于26的补充剂 • 甘油三酯（TG）形式而非乙酯（EE）形式——吸收显著更好 • 深色玻璃或不透明容器，存放在冰箱中

**藻油：** 直接提供DHA+EPA，来源于原始来源（鱼从藻类中积累EPA/DHA）。对经历“鱼打嗝”的人更易耐受。环保的选择。关于心血管影响的证据正在出现，但与鱼油相比仍然有限。

Understanding omega-3 fatty acids' anti-inflammatory action requires understanding their relationship with omega-6 fatty acids, specifically arachidonic acid (AA). When cells are damaged or stimulated, phospholipases release fatty acids from cell membrane phospholipids as signalling precursors. If AA is released, it is metabolised by cyclooxygenase and lipoxygenase enzymes to produce pro-inflammatory prostaglandins, leukotrienes, and thromboxanes (2-series and 4-series eicosanoids). If EPA is released instead, the same enzymes produce 3-series and 5-series eicosanoids that are significantly less potent inflammatory mediators. The balance between AA and EPA in cell membranes — which directly reflects dietary intake patterns over preceding weeks and months — therefore determines the inflammatory tone at the cellular level. Additionally, EPA and DHA give rise to a family of recently characterised pro-resolving mediators — resolvins, protectins, and maresins — that actively terminate inflammatory responses, promote tissue clearance of cellular debris, and facilitate return to homeostasis. This resolution phase of inflammation is increasingly understood as critically important: chronic inflammation in many modern diseases may represent not excessive inflammatory initiation but failure of resolution, and EPA/DHA-derived mediators are central to this resolution biology. The practical implication is that reducing omega-6 intake (primarily by reducing consumption of refined vegetable oils such as sunflower, corn, and soybean oil) while increasing omega-3 intake from marine sources creates a more anti-inflammatory cellular environment — a dual dietary strategy more powerful than increasing omega-3 intake alone.

Fish oil is the most widely used omega-3 supplement globally, but quality varies enormously. The key parameters to look for are total EPA and DHA content per dose, oxidation status, purity from heavy metals and PCBs, and form of the omega-3 (triglyceride vs ethyl ester). Natural triglyceride-form fish oils are generally better absorbed than ethyl ester forms — particularly when taken without food — though high-quality ethyl ester products taken with fat can match triglyceride bioavailability. Oxidation is a significant quality concern: rancid fish oil generates toxic oxidation products, smells unpleasant, and may paradoxically increase cardiovascular risk. Always look for products that have been independently tested for oxidation markers (TOTOX score) and contaminants. Third-party certifications from IFOS (International Fish Oil Standards), GOED, or NSF International provide meaningful quality assurance. For general health maintenance, 1–2g combined EPA and DHA daily is a typical evidence-based dose. For specific conditions — triglyceride reduction, depression management, or pregnancy — doses of 2–4g are commonly used. Krill oil is an alternative to fish oil; it contains phospholipid-bound EPA and DHA which may be slightly better absorbed at lower doses, plus the antioxidant astaxanthin. Algae oil is the recommended choice for vegans and those who prefer to avoid fishy taste or sustainability concerns — it is often DHA-dominant and some formulations include EPA. Cod liver oil provides EPA and DHA alongside significant quantities of vitamins A and D, which can be an advantage but also requires attention to upper limits for fat-soluble vitamins. Store fish oil in the refrigerator after opening to slow oxidation.